Page last updated: 2024-08-05 11:55:11
organic peroxide
Compounds of structure ROOR' in which R and R' are organic groups.
ChEBI ID: 25702
Members (7)
| Member | Definition | Role |
|---|---|---|
| artemether | An artemisinin derivative that is artemisinin in which the lactone has been converted to the corresponding lactol methyl ether. It is used in combination with lumefantrine as an antimalarial for the treatment of multi-drug resistant strains of falciparum malaria. | artemether |
| artemisinin | A sesquiterpene lactone obtained from sweet wormwood, Artemisia annua, which is used as an antimalarial for the treatment of multi-drug resistant strains of falciparum malaria. | (+)-artemisinin |
| ascaridole | A p-menthane monoterpenoid that is p-menth-2-ene with a peroxy group across position 1 to 4. | ascaridole |
| ergosterol-5,8-peroxide | An ergostanoid that is ergosta-6,22-dien-3-ol with a peroxy group between positions 5 and 8 (the 3beta,5alpha,8alpha,22E stereoisomer). Isolated from Ganoderma lucidum and Cordyceps sinensis, it exhibits antimycobacterial, trypanocidal and antineoplastic activities. | ergosterol peroxide |
| fumitremorgin a | An organic heterohexacyclic compound that is a mycotoxic indole alkaloid obtained by prenylation of the 10-hydroxy group of verruculogen. | fumitremorgin A |
| nitrosoperoxycarbonate | A carbon oxoacid that is carbonic acid in which one of the hydrogens is replaced by a nitrosoxy group. At physiological pH, nitrosoperoxycarbonic acid is highly unstable, rapidly decomposing to give CO2, NO2, and hydroxyl radicals. | nitrosoperoxycarbonic acid |
| verruculogen | An organic heterohexacyclic compound that is a mycotoxic indole alkaloid isolated from Penicillium and Aspergillus species. | verruculogen |
Research
Studies (3,807)
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 182 (4.78) | 18.7374 |
| 1990's | 401 (10.53) | 18.2507 |
| 2000's | 907 (23.82) | 29.6817 |
| 2010's | 1,730 (45.44) | 24.3611 |
| 2020's | 587 (15.42) | 2.80 |
Study Types
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 370 (9.05%) | 5.53% |
| Reviews | 531 (12.98%) | 6.00% |
| Case Studies | 93 (2.27%) | 4.05% |
| Observational | 12 (0.29%) | 0.25% |
| Other | 3,084 (75.40%) | 84.16% |